Botswana’s Ministry of Health has acknowledged the potential impact of the U.S. Government’s immediate suspension of foreign aid, noting that it could affect local health programs—especially if the suspension becomes permanent. According to Ministry spokesperson Dr. Christopher Nyanga, many U.S.-funded civil society organizations in Botswana have already been instructed to halt their operations.
Dr. Nyanga explained that Botswana has benefited from significant American assistance for decades, particularly through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the United States Agency for International Development (USAID), and the Centers for Disease Control and Prevention (CDC). Since PEPFAR’s introduction in 2003, Botswana’s health sector has received over P1 billion in support, helping the country become one of the first in the world to surpass the UNAIDS 95-95-95 targets ahead of schedule.
Despite concerns, Dr. Nyanga emphasized that Antiretroviral (ARV) medication availability will not be compromised, as it is directly procured by the Botswana government. He added that the Ministry is in discussions with stakeholders, including the U.S. Embassy, to find ways to sustain key health services if the suspension remains in effect.
“Like many countries across the world, Botswana has been fortunate to receive generous aid from the U.S. for many decades,” Dr. Nyanga said, “and that support has been instrumental in growing our health sector and enabling us to achieve critical HIV/AIDS milestones.”
